Featured Researchers - Fred Hutchinson Cancer Research Center

Featured Researchers

Fred Hutch scientists are among the world’s most innovative and creative researchers. They work in a setting that stresses the scientific freedom needed to achieve research breakthroughs. Read our profiles of selected researchers below to learn more about their unique work.

For more information, view the complete list of Hutch faculty members and visit the online portal for labs and research groups.

View by topic:

Alphabetical Listing:

Select a letter to display a list of Faculty members
A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  [Show All]
Director, Public Health Sciences Division
Anderson lends her skills as a scientist and biostatistician to designing, conducting and analyzing data from large population studies, collaborating with colleagues to make breakthrough discoveries that have helped save hundreds of thousands of lives, billions of dollars and untold amounts of suffering.
Executive Vice President and Deputy Director, Fred Hutch
When Appelbaum was a medical student, he happened upon an early write-up of bone-marrow transplantation by Dr. E. Donnall Thomas, who later won a Nobel Prize for the pioneering blood-cancer treatment. Little did he know that one day he'd have Thomas' job at the Fred Hutch.
Cancer geneticist and lung cancer researcher
With her sights set on pinpointing new cancer treatment targets, Berger develops methods to assess the biological consequences of thousands of different gene mutations at once. And she’s exploring the direct role that specific mutations may play in the development of lung cancer.
Geneticist and cell biologist
Biggins's breakthrough discoveries about how cells divide could lead to drugs that stop cancer cells from propagating.
Evolutionary and computational biologist
Bloom's research focuses on the evolution of viruses and on halting their drug-resistance.
Psychologist and smoking-cessation expert
By combining cutting-edge psychology and technology, Bricker is working to help millions of people adopt healthier habits that reduce their cancer risk.
Through years of intensive research, Buck became the first to identify a family of genes that control the olfactory system, a complex network that governs our sense of smell.
Assistant Member, Clinical Research Division
Chapuis is a physician and immunotherapy researcher focused on improving T-cell therapies for patients with cancer.
Director, Cancer Immunotherapy Trials Network
Cheever is internationally recognized for his contributions to cancer immunotherapy, particularly in the area of cancer vaccines.
Executive Vice President and Deputy Director, Fred Hutch
Clurman studies molecular pathways that drive cells to multiply, with the ultimate goal of designing therapies that encourage cancerous cells to accelerate toward a deadly crash.
Director of the Basic Sciences Division
Cooper focuses on advancing our fundamental knowledge of biology, with the goal of finding building blocks that help us understand and defeat cancer.
Virologist and Fred Hutch president and director emeritus
As a scientist, Dr. Larry Corey has led some of the most significant advances in medicine in the last 30 years: the development of safe and effective antivirals for herpes viruses, HIV, and hepatitis infections.
Cord blood transplant program director
By harnessing the healing power of umbilical cord blood, Delaney is on the forefront of developing a treatment that may prove to be a landmark breakthrough for deperately ill leukemia patients.
immunologist, regenerative medicine researcher
Dudakov studies the thymus, a specialized organ that is central to a healthy immune system. By understanding how the thymus regenerates after damage, he hopes to develop treatments that improve immune function and boost vaccines, reduce chemotherapy complications, and improve the effectiveness of immunotherapies.
Blood-cancer physician and clinical researcher
As a trial principal investigator, Egan is on the front lines of caring for patients enrolled in clinical trials of new immunotherapies developed in the labs at Fred Hutch.
Oncologist and clinical researcher
By studying how cells exchanged between fetus and mother connect to cancer, Gadi's research could open a door to improved cancer detection and treatment.
Microbiologist and expert in pathogen-associated malignancies
Galloway's breakthrough research helped pave the way to the cancer-preventing human papillomavirus (HPV) vaccine, and she continues to apply her expertise to reduce the worldwide burden of cancers caused by infectious agents.
Bioengineer and cancer researcher
A “whimsical” decision to study bioengineering started Dr. Cyrus Ghajar on a path that has led him to a new frontier in cancer research — one that could eventually lead to new methods for preventing cancer’s spread
Scientific Director, Translational Data Science IRC
Gottardo operates at the center of the busy intersection of biology, data science and technology. He aims to bring scientific discoveries from research labs to the bedside sooner using data-driven approaches.
Cancer geneticist
Ask Grady about the link between medical research and patient treatment and he’ll tell you about the new drug therapy that helped extend his mother’s life.
Head of immunology
Greenberg is a world expert in discovering how rare disease-fighting cells, called T-cells, can be manipulated to treat a range of cancers—and with milder side effects than traditional therapies.
Cancer prevention and integrative medicine researcher
Dr. Heather Greenlee was 17 when her stepfather was diagnosed with glioblastoma. That experience led her to pursue a career in cancer prevention research and integrative medicine. She's now doing cancer survivorship research at Fred Hutch as well as serving as medical director of the Integrative Medicine Program at Seattle Cancer Care Alliance.
Molecular biologist and special advisor to the director's office
Groudine says he's "not at all a top down kind of leader—I give people responsibility and turn them loose." Meanwhile, his own research as an award-winning molecular and cellular biologist has earned him international renown.
Cancer biologist
Gujral takes a multidisciplinary approach to study how a tumor’s environment affects tumor cell behavior, including growth, metastasis and resistance to therapy
Geneticist and inventor
Renowned for his genetic research, Henikoff has developed widely used computer programs and a wealth of other research tools that have led to breakthroughs in many areas of basic science.
Director of Hematopoietic Stem Cell Transplantation, Fred Hutch and Seattle Cancer Care Alliance
Hill's research on transplantation immunology has paved the way for new drugs and "huge progress" in graft-vs.-host disease, a common complication of bone marrow transplants.
Oncologist and pancreas cancer researcher
Hingorani's work has yielded some of the most significant advances in decades related to early detection and treatment of pancreas cancer, a disease that is almost uniformly a death sentence by the time it is detected.
Director of Human Biology Division
Holland is a physician and a scientist, a common combination in the world of medical research. Less common is the demanding combination he chose—neurosurgery and molecular biology.
Lung cancer immunologist
Neutrophils are immune cells designed to help save your life. So, in lung tumors, why are they working against you? Houghton is on the case.
Molecular and cell biologist and oncologist
Hsieh plumbs an under-examined area of cancer cell biology — control of protein synthesis — to identify new therapies for difficult-to-treat cancers.
Gastroenterologist and health services researcher
“Screening is a way to not only prevent disease but reduce racial and economic disparities,” said Issaka, who is on the faculty of the Hutch’s Clinical Research Division and the Hutchinson Institute for Cancer Outcomes Research. “We need to close that gap so that every citizen can benefit from the advances in cancer care and prevention.”
Cancer researcher
Kemp studies both the environmental and genetic factors that lead to cancer, with an emphasis on inquiries that have a significant potential for improving patient care.
Oncologist, stem cell and gene therapy researcher
Kiem investigates how stem cells can be extracted, manipulated at a genetic level and delivered back to sick patients to treat a range of diseases, from infections like HIV to aggressive cancers.
Blood-cancer specialist and epidemiologist
The idea behind algorithm-informed treatment is to harness computing power to do what the human mind cannot: provide an unbiased, evidence-based look at the relative risks and benefits of a patient’s many different treatment options at a given moment, especially when there is no gold-standard data available or when the patient differs in important ways from clinical trial participants.
Transplant physician-scientist
Inspired by the memory of a boy whose life was taken too soon, Lee’s research helps patients undergoing potentially lifesaving, but risky, transplants of blood-forming stem cells.
Li is identifying important connections between breast cancer and factors such as medications, alcohol and obesity.
Virus researcher
Linial is a leader in researching foamy viruses, a type of animal virus that could jump to humans and affect their health.
Oncologist, health economist and HICOR co-director
While many researchers at Fred Hutchinson Cancer Research Center are trying to find cures for cancer, Dr. Gary Lyman has an equally daunting task: finding a cure for cancer’s skyrocketing costs and the financial toll it can take on patients and their families.
Pulmonary Researcher
Dr. David Madtes’ specialized, multidisciplinary clinic is one of only a few in the country that assesses people’s risk of lung cancer and expedites evaluations of suspicious findings, using state-of-the-art diagnostic techniques.
Evolutionary geneticist
Malik studies the evolutionary struggle between viruses and humans. Ultimately, his research may lead to new drugs to fight HIV.
Immunotherapy researcher and oncologist
Maloney has played a pivotal role in developing targeted treatments that rely on special molecules called antibodies to fight cancer, including a paradigm-changing drug for lymphoma patients.
Oncologist and transplantation researcher
The veteran leukemia researcher is devoted to improving the lives of patients who receive bone marrow or blood stem cell transplants.
HIV vaccine researcher
As one of the leaders of a massive international effort to develop a preventive vaccine for HIV, McElrath has spent more than two decades at the forefront of the war on AIDS.
Cancer prevention researcher
McTiernan's groundbreaking studies have produced some of the first specific answers about the role of exercise and weight loss in reducing cancer risk, earning her a spot on a federal advisory committee.
Developmental biologist
Moens studies brain development in transparent zebrafish embryos. Cutting-edge technology and the fish’s unique characteristics have enabled her to make discoveries not possible in any other system.
Oncologist and cancer researcher
Mostaghel works to improve our understanding of what makes cancer treatments successful and how best to target them to patients, with a focus on prostate cancer.
Autoimmunity researcher and rheumatologist
Nelson's pioneering work on the mother-child cell transfer that happens during pregnancy, known as microchimerism, could form the basis for new therapies for people with autoimmune diseases like rheumatoid arthritis, scleroderma and diabetes.
Prostate cancer researcher and oncologist
Nelson leads investigations that seek new, more precise ways of individualizing care for prostate cancer's varied forms.
Newell is an expert in the use of mass spectrometry, a workhorse technology in chemistry and physics, to analyze proteins in T cells, key components of the human system.
Brain cancer researcher
Olson is focused on developing new ways to remove brain tumors, finding new treatments for tumors that have few therapy options and identifying new uses for existing drugs.
HIV researcher
Overbaugh seeks to understand the fundamental biology of HIV in order to inform development of preventive measures such as vaccines.
Employing a cutting-edge technology called RNA interference, Paddison investigates why cells behave in particular ways--work that could lead to better therapies for many diseases.
Oncologist and cancer geneticist
Paulovich's lab develops technologies aimed at rapidly screening large numbers of telltale proteins—known as "biomarkers"—for clues that may indicate the earliest stages of cancer and other diseases.
Radioimmunotherapy researcher and oncologist
Some of the world's most successful treatments for lymphoma and other blood cancers have emerged from research by Press and colleagues, who pioneered the use of radioactive molecules that blast cancer with high doses of radiation while sparing healthy cells.
Leukemia Researcher
Radich’s research has led to important breakthroughs in leukemia detection and treatment since he came to Fred Hutch 25 years ago. His work involves sniffing out tiny numbers of cancer cells based on their genetic signature.
Physician, cancer researcher, and health economist
When Ramsey talks about medicine, his upturned palms often rise to form an imaginary scale. As a physician, cancer researcher and health economist, he weighs the cost and benefit of various treatments, doggedly advocating for the best patient care for the least amount of money.
Immunotherapy researcher and oncologist
Riddel is fortifying the immune system with better weapons: long-living T-cells specially engineered to seek and destroy cancer.
Immunology researcher
Rongvaux studies the innate immune system, the first responder of the body’s defense system. He wants to know: How does the innate immune system recognize abnormal cells like cancer?
Cell biologist
Growing up in an orphanage in Hershey, Pa., Roth often heard "no" from the adults in his life. No, he couldn't run on the high-school track or cross-country teams. No, he'd never be a scientist. Now his research may one day transform emergency medicine.
Salama studies Helicobacter pylori, a cancer-linked bacterium that relies on its unusual corkscrew shape to burrow into the stomach lining, sometimes triggering ulcers and gastric cancer.
Oncologist and liver cancer researcher
Dr. Saha studies a deadly, difficult-to-detect form of liver cancer known as intrahepatic cholangiocarcinoma. His goal is to deeply understand ICC so that he can develop targeted treatments as well as effective strategies for early diagnosis and prevention.
Oncologist, health economist and HICOR co-director
A passion for patients, policy and the philosophy of cancer care combine to help Shankaran take on cancer’s financial toxicity.
Blood cancer physician and outcomes research scientist
With his research, Sorror is erecting trail markers that help blood-cancer patients and their doctors choose the best way to go when they are presented with diverging paths of care.
Director of Program in Prostate Cancer Research
The hope of cancer prevention motivates Stanford on a very personal level. Five of her close family members have fought the disease. "I look at my son," she says, "and I am inspired to do something to prevent him from getting prostate cancer like both of his grandfathers."
Structural biologist
In his laboratory at the Hutchinson Center, Dr. Barry Stoddard uses some of the most advanced technology in the world to probe the structure and function of biological molecules atom by atom.
Head of Transplantation Biology Program
Much of what scientists have learned—and are still learning—about the biology of stem-cell transplantation came from Storb's laboratory. He continues to pioneer new blood-cancer treatments after working on team led by Dr. E. Donnall Thomas, the father of bone marrow transplantation.
With his expertise in determining molecules’ structures and functions, Strong collaborates with clinicians to design and create new diagnostics and therapeutics.
Cancer biologist
Taniguchi delves into a natural process called DNA repair to shed light on a phenomenon that has long vexed oncologists: why anti-cancer drugs often decline in effectiveness over time.
Transplant biologist and mentor
Torok-Storb overcame the odds to become a scientist who has helped improve patients’ outcomes following transplants of blood-forming stem cells. Now she’s inspiring the next generation of researchers to make their own discoveries.
Turtle, a hematology oncologist, is working toward harnessing the body's own immune system to fight cancer. Turtle’s research focuses on a subset of T cells known as central memory T cells, which are one of the keys to our ability to develop immunity from viral infections — and someday could free cancer patients from their disease.
Immunotherapy researcher and oncologist
From blood stem cell transplantation to immune-boosting drugs, Warren wants to know how complex immunotherapies work and how they can fail. His goal is to use this knowledge to develop better immunotherapies for diseases from kidney cancer in the U.S. to lymphomas in Africa.